or Try an Advanced Search...

    Technical Analysis for YS - YS Biopharma Co., Ltd.

    Grade Last Price % Change Price Change
    B 0.81 -0.11% 0.00
    YS closed down 0.11 percent on Wednesday, April 24, 2024, on 12 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Down
    Historical YS trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -0.11%
    Crossed Above 200 DMA Bullish -0.11%
    Stochastic Reached Oversold Weakness -0.11%
    Wide Bands Range Expansion -0.11%
    Gapped Up Strength -0.11%
    Oversold Stochastic Weakness -0.11%
    20 DMA Resistance Bearish 9.31%
    Older End-of-Day Signals for YS ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 18 hours ago
    Possible NR7 about 19 hours ago
    60 Minute Opening Range Breakdown about 22 hours ago
    Rose Above Previous Day's High about 23 hours ago
    Up 1% about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    YS Chart by TradingView
    Basic chart:

    Profile

    YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Infectious Diseases Vaccines Influenza Coronavirus Hepatitis B Vaccination Shingles Rabies Vaccine Preventable Diseases

    Is YS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 18 YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
    Apr 16 YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024
    Apr 9 YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
    Apr 3 YS Biopharma announces full repayment of $40M loan facility
    Apr 3 YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
    Mar 5 YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
    Feb 22 YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
    Feb 18 /C O R R E C T I O N -- YS Biopharma Co., Ltd./
    Feb 9 YS Biopharma announces $40M private placement
    Feb 9 YS Biopharma Announces US$40 Million Private Placement Financing
    See more YS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.97
    52 Week Low 0.351
    Average Volume 204,223
    200-Day Moving Average 0.74
    50-Day Moving Average 0.65
    20-Day Moving Average 0.83
    10-Day Moving Average 0.83
    Average True Range 0.09
    RSI (14) 53.70
    ADX 52.6
    +DI 22.61
    -DI 11.21
    Chandelier Exit (Long, 3 ATRs) 0.74
    Chandelier Exit (Short, 3 ATRs) 0.86
    Upper Bollinger Bands 0.96
    Lower Bollinger Band 0.69
    Percent B (%b) 0.45
    BandWidth 33.71
    MACD Line 0.04
    MACD Signal Line 0.06
    MACD Histogram -0.0195
    Fundamentals Value
    Market Cap 75.38 Million
    Num Shares 93.1 Million
    EPS -0.57
    Price-to-Earnings (P/E) Ratio -1.42
    Price-to-Sales 0.07
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.84
    Resistance 3 (R3) 0.84 0.83 0.84
    Resistance 2 (R2) 0.83 0.83 0.83 0.84
    Resistance 1 (R1) 0.82 0.82 0.82 0.82 0.83
    Pivot Point 0.81 0.81 0.81 0.81 0.81
    Support 1 (S1) 0.80 0.80 0.79 0.80 0.79
    Support 2 (S2) 0.79 0.80 0.79 0.78
    Support 3 (S3) 0.78 0.79 0.78
    Support 4 (S4) 0.78